To determine whether the erythropoietin receptor (Epo-R) plays a role in the course of malignant erythropoietic disorders, this gene was studied in murine and human erythroleukemia cells. An altered Epo-R gene was found in a murine Friend erythroleukemia cell line, FCL1, due to a spleen focusforming virus (SFFV) long terminal repeat insertion within the noncoding region of the first exon, leading to Epo-R mRNA overexpression. A similar mechanism of Epo-R adivation has previously been described in the T3CL-2 Friend erythroleukemia cell line. An elevated number of Epo-binding sites has been observed in two human erythroleukemia cell lines, TF-1 and UT7. In UT7 cells, homogeneously staining region of the short arm of chromosome 19 [hsr (1911 was E RYTHROPOIETIN (Epo) stimulates proliferation and/ or differentiation of erythroid progenitor cells by binding to specific membrane receptors. The erythropoietin receptor (Epo-R) is a member of the cytokine receptor superfamily'.* that includes receptors for such cytokines as interleukin (1L)-2, IL-3, IL-4, IL-5, IL-6, L-7, IL-9, granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF), leukemia inhibitory factor (LIF), and oncostatin, as well as for growth hormone, prolactin, and the ciliary neurotrophic f a~t o r .~ The cloned Epo-R chain possesses the common structure described for this receptor superfamily, characterized by a cytoplasmic domain without kinase catalytic activity, a single membrane-spanning domain, and an extracellular domain containing a set of four spatially conserved cysteine residues and a membrane-proximal Trp-Ser-X-Trp-Ser motif. Different modifications in the activation of some cytokine receptors, such as constitutive activation by interaction with retroviral glycoproteins or mutation in the extracellular domain, have been shown to be important steps in leukemic processes? Thus, the interaction between the envelope glycoprotein of Mink cell focus-forming viruses and the IL-2 receptor induces a growth factor-independent proliferation of lymphoid cell^.^,^ Similarly, the glycoprotein gpS5 encoded by the env gene of the polycythemia-inducing Friend spleen focus-forming virus (SFFVp) can interact with the Epo-R. Binding of gp55 to Epo-R appears to mediate the Epo-independent proliferation of SFFVp-infected proerythroblasts during the preleukemic stage of the Friend disease.' Recent data, in accordance with those previously published,8 showed a correlation between the occurrence of the SFFVp-Epo-R complexes expressed at the cell surface and the SFFV pathogenic potential?." Constitutive activation of the Epo-R in the absence of viral products has also been documented, since a single mutation located at codon 129 in the Epo-R extracellular domain (replacement of an Arg by a Cys residue) constitutively triggered the activation of this receptor in the absence of Epo addition." It is noteworthy that a retrovirus carrying this mutated form of Epo-R gained oncogenic properties and induced erythroleukemia with polycythemia in susceptible mice.I2
Indeed, a highly significant linkage between a familial erythrocytosis and a polymorphism of the Epo-R gene was estab-1i~hed.I~ In human myeloid cell lines with erythroid potentiality, the exact role of Epo and its receptor in the occurrence and development of erythroleukemia remains to be elucidated. KS62,14 HEL,I5 and OCIM116 cell lines harbor variable numbers of Epo-binding sites, but do not respond to Epo. KU812" and JK1" cells are sensitive to Epo. Epo increases hemoglobinization in KU812 cells, whereas it enhances the plating efficiency of JK1 cells, which spontaneously differentiate into red blood cells. Two more recently established human leukemia cell lines, TF-lI9 and UT7,20 are strictly growth factor-dependent for their proliferation, and Epo is required for the appearance of erythroid differentiation features in UT7 cells." The heterogeneity in the response to Epo of these different leukemia cell lines raises the question of the structure and functionality of the Epo-R in these cells.
We previously described a DNA rearrangement of the Epo-R gene in the T3CL-2 Friend-induced erythroleukemia cell line related to a retroviral insertion and leading to Epo-R transcriptional activation. 22 In this report, we analyzed the Epo-R gene structure and expression in other murine and human erythroleukemia cells. We found that in another Friend erythroleukemia cell line, FCL1, the Epo-R gene is altered by a mechanism similar to that described for T3CL-2. Moreover, we found a complex alteration of the Epo-R gene in the human UT7 cell line, characterized by an amplification of the Epo-R locus and a genomic rearrangement located outside the coding sequence, 3 kb 3' from the end of the last exon of the Epo-R gene.
MATERIALS AND METHODS
Erythroleukemia cell lines and tumors. Murine erythroleukemia cell lines were cultured in alpha medium plus 5% heat inactivated fetal calf serum (FCS) in a humidified incubator (5% COz, 95% air) at 37°C. Different cell lines were studied, including polycythemic Friend-induced erythroleukemia cells T3CL-2, FCLl, TFP10, F4N, F4+, FLC, 707, and 745; anemic Friend-induced erythroleukemia cells CTF 23-30; Rauscher erythroleukemia cells Red 5-1.523; and helper F-MuLV-induced cells IW32, IW35, 201 IW32, NN10. 24 The two human factor-dependent erythroleukemia cell lines UT7 and TF-l were grown in alpha medium containing 10% FCS and 2.5 n g h L recombinant human GM-CSF, whereas KU812 and JK1 cell lines were grown in RPM1 1640 containing 10% FCS.
Most primary Friend tumors were isolated from spleen and liver of ICFW mice infected with the polycythemic Friend viral complex (Lilly and Steeves SFFV strain or Ikawa SFFV strain) or with the anemic Friend viral complex. Some tumors were isolated from CBA or DBM2 mice infected with the Lilly and Steeves SFFV strain as previously described.*'
Polymerase chain reaction amplification of murine erythroleukemia genomic DNA. Oligonucleotides were synthesized on a Milligen Biosearch 8700 DNA synthesizer (Millipore, Bedford, MA) and purified on a 20% acrylamide urea gel. The oligonucleotide position and sequence used for polymerase chain reaction (PCR) amplification and sequencing have been described previously. 22 Briefly, INTS-310 5'-(AACTCTGCTGTCTGCCCCA)-3' is an oligonucleotide located at the Epo-R promoter region, and INTS-190 primer 5'-(CCA-GGCTGCCCCAGCAAGTA)-3' corresponds to the Epo-R exon 1.
Genomic FCLl DNA (1 p g ) was added to 100 pL of a PCR mixture containing buffer, dNTPs (10 mmol/L), 2.5 U Taq polymerase (Perkin Elmer Cetus, Norwalk, CT), and 1 mmol/L of each oligonucleotide primer. The amplified fragments were electroeluted and cloned in pUC18 as described previously.2z Inserts from recombinant pUC18 vectors were sequenced on both strands by the dideoxy chain termination method (Sanger) with a Pharmacia T7 sequencing kit (Pharmacia, Uppsala, Sweden), using universal primers or specific oligonucleotides as internal primers.
Western blot analysis. Sample preparation, electrophoresis, and transfert were performed as previously described.26 A goat antiserum to purified Rauscher Envelope (Env) protein was kindly provided by Dr J. Gruber, National Cancer Institute, Bethesda, MD. This antiserum recognizes the F-MuLV and the SFFV Env proteins. It was used at a U250 dilution for Western blots. An alkaline phosphataselabeled rabbit anti-goat IgG antiserum was purchased from Sigma (St Louis, MO). The revelation was performed using the nitroblue tetrazolium (NBT)/S-bromo 4-chloro-3 indolyl phosphate (BCIP) method.
Northern blot analysis. Total cellular RNA from different cell lines was extracted according to the method of Chirgwin et aI2'; after glyoxal denaturation, 20 pg of total RNA was electrophoresed and transferred to Genescreen membranes (Dupont NEN, France).
Southern blot analysis. High-molecular weight DNAs were digested with restriction endonucleases; 10 pg was blotted to nylon membranes after electrophoresis and hybridized to the "P-labeled probes.
cDNA and genomic probes. Genomic and cDNA murine Epo-R probes have been described previously.z2 Human Epo-R probes have been isolated from cDNA and genomic clones.28 For fluorescence in situ hybridization (FISH) analysis, the Epo-R probes (two genomic insert DNAs encompassing 15 kb of the Epo-R gene) and the low-density lipoprotein receptor (LDL-R) probe (genomic insert DNA of 5.3 kb in pcDVl vector, ATCC 57005; ATCC, Rockville, MD) were digoxigenin-labeled by nick translation according to the Boehringer protocol (Boehringer Mannheim, Mannheim, Germany). The chromosome 19-specific painting probe was used according to the Oncor protocol (Gaithersburg, MD). A 3-kb genomic fragment corresponding to the minor cluster region of Bc12 gene, provided by C.J. Larsen, INSERM U301, Paris, was used as a standard for quantification.
Chromosome preparation and FISH. Slides containing metaphase spreads of the UT7 cell line were prepared by standard procedures and treated with 5-bromodeoxyuridine (BrdU) to induce R-banding.29 Hybridization was performed using the Epo-R and LDL-R probes at a concentration of 10 nglpL with 50-fold excess human total DNA as competitor. For double-color FISH, chromosome 19 biotinylated painting probe and Epo-R probe nick translated with digoxigenin were pooled after denaturation (10 pL of the painting probe and 10 pL of the Epo-R probe at the concentration of 15 ng/pL with 50-fold excess human total DNA). After overnight hybridization at 37°C. the slides were rinsed, then incubated sequentially with antibiotin (goat) antibody (Vector Laboratories, Burlingame, CA), antidigoxigenin (mouse) antibody (Boehringer), fluorescein isothiocyanate (FITC)-conjugated antigoat antibody (Biosys, Compiegne, France), and finally with sheep rhodamine-conjugated anti-mouse antibody (Boehringer). Slides were stained with propidium iodide (0.1 pglmL), briefly rinsed, and mounted in a solution of antifade p-phenylenedianine (PPD). Green and red fluorescence were viewed through a double-band pass filter (Omega Optical, Brattleboro, VT), on a conventional epifluorescence microscope without any image processing technique. Metaphases were photographed using Ektachrome ASA 400 film (Kodak, Rochester, NY).
RESULTS

Study of Epo-R gene structure in murine erythroleukemia cell lines and tumors.
Several murine erythroleukemia cell lines were tested for the presence of Epo-R genomic rearrangements. Southern blot analyses were performed using a probe containing sequences located 5' to the transcription initiation site and encoding the first exon of the Epo-R gene.22 Among 13 cell lines tested, one cell line, FCLI, had a rearranged Epo-R allele. The size of the rearranged fragment appeared identical to that previously described for the T3CL-2 cell line ( Fig IA) , which was shown to contain a viral LTR insertion.22 Two oligonucleotides, INTS 310 and INTS 190, located 5' and 3', respectively, of the T3CL-2 DNA rearrangement, were used to perform a PCR amplification on FCLl DNA. In addition to the normal fragment (354 bp), a 0.5-kb longer fragment (869 bp) was obtained, which corresponded to the rearranged allele (data not shown). After cloning and sequencing of this fragment, it appeared that a viral long terminal repeat (LTR) sequence was inserted in the first exon of the Epo-R gene, 5' of the coding sequence. Thus, the nature of the rearrangement in FCLl was similar to that described for T3CL-2. However, the viral insertion in the FCLl and T3CL-2 Epo-R genes exhibited differences: (1) the LTR insertion in FCLl was localized 8 bp upstream from the T3CL-2 insertion and the duplication of five nucleotides flanking the LTR insertion was GGACG in FCLl and CAGGG in T3CL-2 ( Fig IB) ; and (2) there were 10 nucleo- tide differences between the two LTR sequences (data not shown). We further assessed the independent origin of the two cell lines by hybridizing genomic DNAs with Spi-l and p53 probes, two genes known to be frequently altered in Friend erythroleukernias.'"'' After hybridization with Spi-l and p53 probes, an additional band was seen in FCLl and T3CL-2 DNAs when compared with normal DNA from DDD mice, and it is noteworthy that these two cell lines harbored different hybridization patterns (Fig 2) . These results definitely exclude cell line contamination and indicate that these two cell lines have a different origin. The viral LTR insertion led to Epo-R mRNA overexpression in FCLI cells ( Fig 3A) . However, the number of Epo-binding sites determined by "'I-Epo fixation to the cell surface was not increased ( 1 .000 Epo-binding sites per cell). It has been shown that the gp55 Env protein of the Friend SFFV could retain the Epo-R intrace1Iulary3'; as a consequence, the presence of the gp55 Env was verified by Western blot analysis: both cell lines expressed high levels of pp55 Env protein ( Fig 3B) . Since FCLl and T3CL-2 cell lines were established in culture a long time ago, we were unable to determine whether the alteration of the Epo-R gene had occurred in vivo or during the in vitro expansion of these cells. We therefore screened 23 Friend primary tumors isolated from Friend virus-infected mice for Epo-R rearrangement. Two probes were used for the analysis of the Epo-R gene: the previously described 5' genomic probe, and a I .7-kb cDNA fragment corresponding to the whole coding sequence. No rearrangement could be detected in these tumors.
Epo-R rrhtlonnnlities it1 hwtznn enthroleukemin cell lines.
The number of Epo-binding sites on the cell surface of the human erythroleukemia cell lines is quite heterogeneous. Some. such as K562, HEL. JK I , and KU8 12, harbor a low number (<300/ceII). while others. such as OCIMI, UT7, and TF-1. exhibit a high number of Epo-binding sites (from 3.000 to I 1,0001cell).
The TF-I erythroleukemia cell line is dependent on various hematopoietic growth factors for its proliferation and harbors I . 5) .
By Southern blot analysis, no abnormality was observed at the 5' end of the Epo-R gene for the four cell lines tested, KU812. JKI, TF-I, and UT7, when the 5' probe was used; in contrast, Southern blot analysis with probe A, located at the 3' end of the gene, demonstrated the presence of abnormal Epo-R gene fragments in both TF-I and UT7 DNAs ( Fig 4A) . In TF-I DNA, in addition to germ-line fragments (SacI, 9.2 kb; BgllI, 25 kb; HindllI, 5 kb; BarnHI, 4.3 kb), new fragments (Sad, 4 kb; BgIII, 5 kb; HindIIl, 3.5 kb;
BarnHI, 6 kb) were observed, showing that these cells had one rearranged Epo-R allele as previously described by Ward 15 kb were observed with Sac1 and BgnI restriction enzymes, respectively, but not with Hind111 or BamHI. To map the rearrangement breakpoint more precisely, we isolated an Epo-R genomic probe located further 3' (probe B, Fig 5) .
As shown in Fig 4B, this probe showed that, in UT7 DNA, ( I ) the same two Sac1 fragments, normal and rearranged, were detected with probes A and B; (2) in addition to germline alleles (BarnHI-, 9 kb; HindIII-, 5 kb), rearranged alleles were identified in both digests with probe B (BarnHI, 13 kb; HindII, 7 kb); and (3) no rearrangement was observed with this B probe in TF-I BarnHI-, HindlII-, and Sad-digested DNAs. These latter data are consistent with the previously et al."." In UT7 DNA, rearranged DNA fragments of 8 and described location of the breakpoint and the hypothesis of a large deletion of the Epo-R gene, occumng 3' to the breakpoint, in TF-1 DNA.'".3J In UT7 DNA, these results showed that the Epo-R gene was rearranged in all four digests tested, allowing us to exclude a polymorphism of the Epo-R alleles. From these data, a map could be established, indicating that the Epo-R rearrangement in UT7 DNA occurred within a 3.2-kb Hind-Ill-Sac1 fragment localized outside the Epo-R gene coding sequence, 3 kb downstream from the end of the last exon ( Fig 5) . Similar to the TF-I cell line, UT7 overexpressed Epo-R mRNA, which appeared to be structurally normal (data not shown).
KayoQpe [cp 131 ( Fig 6) .
One of the rearranged chromosomes was homogeneously stained after R-banding. Its short arm was similar to the long arm of chromosome 19 and its long arm suggested a possible amplification [homogeneously staining region = hsr (19) ]. Chromosome painting using a chromosome 19-specific painting probe exhibited a positive staining on five chromo--9P55
Fig 3. Expression of Epo-R mRNA and gp55 protein in T3CL-2 and FCLl cell lines. (A) Northern blot analysis of 3 p g of poly A+ RNA hybridized with the full-length murine Epo-R cDNA probe and with an actin probe. (B) Western blot analysis: The proteins from 5 x 10' cells were separated on a 10% polyacrylamide gel, transferred to nitrocellulose, and hybridized with an anti-gp55 Env antiserum. Lane l, 707 cells; lane 2, T3CL-2 cells; lane 3, FCLl cells; lane 4, CTF23-30 cells.
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Hind 111 Baml i I stained, except for the distal segment of the long arm, which was lightly stained ( Fig 7B) . FISH of Epo-R probe, localized on band 19~13.2 by Burdaf et al," exhibited recurrent FISH spots on the two normal chromosomes 19, in a position corresponding to band 19~13.1 or 19~13.2. In addition, a strong signal, corresponding to multiple FISH spots, was observed on one submetacentric, corresponding to the presumed hsr (19) , demonstrating the presence of an amplified sequence. The quantification of the FISH spots was difficult, but up to 12 spots per chromosome (six per chromatid) could be identified. These spots were distributed in a segment corresponding to approximately 30% of the length of the presumed hsr (19) chromosome, localized in the median position of the long arm (Fig 7A) . Chromosome painting and FISH of EpoR probe performed on the same preparations conclusively demonstrated that the submetacentric stained by chromosome painting also hybridized the EpoR probe, and was thus an somes in most metaphases: two normal chromosomes 19; hsr (19) (pl) (Fig 7C) . two small submetacentrics with one arm composed of the In situ hybridization with a LDL-R probe, localized in long arm of chromosome 19 and another of unknown origin:
19~13.3," gave similar results to those of the Epo-R probe der(?)(?; 19)(?;qlI); and one medium-sized submetacentric, on the hsr (19) . suggesting that a large segment of the 19p corresponding to the presumed hsr (19) . almost completely arm was involved in the amplification (data not shown). Finally, these data suggest that in UT7 cells, the chromosome hsr (19) . despite its fairly homogeneous staining (Fig 6) , is composed as follows: ( l ) the 19q arm; (2) the centromere of chromosome 19; (3) the proximal segment of the 19p arm;(4)anamplifiedsegment(l9pl3.1 orp13.2+ 39~13.3); (5) the distal segment of the 19p arm; and (6) a segment of unidentified origin.
Quanrijcation of the Epo-R anzplijcation on Southern blots. To confirm the noticeable amplification of the Epo-R gene evidenced by FISH analysis, we quantified the Epo-R signal detected on Southern blots. UT7 DNA and DNA from human placenta were digested by five different restriction enzymes; the resulting blots were hybridized simultaneously with the Epo-R probe A and with a Bc12 probe used as an internal control. Bc12 gene is located on chromosome 18, two copies of which are present in UT7 cells (see Fig  6) . The Epo-R and Bc12 signals were scanned with a Phos-phorImager 400 (Molecular Dynamics, Sunnyvale, CA), and the ratio of Epo-R to Bc12 in UT7 and normal DNAs was calculated in the five digests, allowing us to determine that the Epo-R gene was amplified 3.7 2 0.5-fold in UT7 cells when compared with normal placental DNA (Fig 8) . This amplification corresponded to 7.4 2 I copies of one Epo-R allele, a result fully consistent with the data obtained by FISH.
DISCUSSION
These results clearly show that Epo-R genomic alterations are not rare events during erythroleukemic processes. Indeed, for virally induced murine erythroleukemia cell lines, two (T3CL-2, FCLI) of 14 tested exhibited Epo-R gene alteration. In addition, Epo-R gene abnormality in the Friend F5-5 cell line has been 
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UT7 cells. By FISH analysis, at least six spots of Epo-R could be identified per chromatid hsr (19) . plus two normal chromosomes 19, giving a total of at least eight Epo-R copies for 82 chromosomes. The quantification of the Epo-R amplification by Southern blot analysis in comparison with Bc12 signal gave a mean number of 7.4 2 1 copies of the Epo-R gene, which is in total agreement with the data given by the karyotype and FISH analysis. In addition, the Epo-R gene appeared rearranged in two (UT7 and TF-l) of four cell lines tested. It remains to be determined whether the actual frequency of this event is higher by analyzing the Epo-R genomic locus with 5' and 3' probes more distantly located. Interestingly, the Epo-R gene alteration in UT7 and TF-I cell lines occurred in a common genomic region localized to the 3' part of the gene. In TF-I cells, the Epo-R gene breakpoint has been mapped to exon 8, 5' to the translation termination codon, whereas the breakpoint in UT7 cells is located further 3'. outside the coding sequence. In both murine and human systems, genetic defects of the Epo-R gene are associated with overexpression of Epo-R mRNA; the resulting excessive activity of the Epo-R is probably involved in the occurrence of leukemogenesis. In human erythroid progenitors, the half-life of the Epo-R mRNA has been determined to be approximately 90 minutes"; an identical half-life for the Epo-R mRNA in UT7 cells was reported by Komatsu and Fujita,'"' indicating that there is no change in mRNA stability. In UT7 cells, the breakpoint is located outside the coding sequence, which implies that the transcriptional unit is unchanged; as a result, it is impossible to differentiate normal from rearranged Epo-R transcripts. Moreover, the mechanism leading to an increase of transcriptional activity in UT7 cells could be due either to the Epo-R gene amplification or to the presence of an exogenous enhancer brought at the 3' end of the gene, or both. Only UT7 and TF-1 human erythroleukemia cell lines with abnormal Epo-R genes express a high number of Epo-binding sites in comparison to their normal counterparts, ie, human erythroid progenitors:' and in comparison to KU812 and JK1 cells, which exhibit 200 and 300 Epo-binding sites, respectively. It is striking that UT7 and TF-l cell lines are both highly responsive to Epo for proliferation and/or differentiation. Similarly, two clones of Ba/F3 cells expressing variable murine Epo-R levels were generated, and the clone expressing the higher Epo-R level was more sensitive to Epo.4' Analogous results were observed in M1 cells transfected with the IL-6-R, which were found to be hypersensitive to IL-6 (by 36-fold) when they display a high number of IL-6-binding sites per ~e l l . 4~
In contrast, for T3CL-2 and FCL l murine erythroleukemia cell lines, there was no correlation between the overexpression of mRNA and the number of Epo-binding sites displayed at the cell surface. The most likely explanation is an intracellular retention of the complex formed by the Epo-R and the gp55 Env protein, as previously described for these Friend erythroleukemia cell lines.7332 Neither of these SFFVp-infected cell lines shows any response to Epo for proliferation or differentiation. However, in these established erythroleukemia cell lines, it is now accepted that gp55 protein is responsible for the constitutive activation of the Epo-R due to the interaction between Epo-R and viral gp55 glyco-In T3CL-2 and FCLl cell lines, interaction between gp55 and the overexpressed Epo-R may provide a positive pressure in the development of erythroleukemia.
The role of Epo-R abnormalities and overexpression in the genesis of human erythroid disorders is not yet clearly established. The fact that Epo-R gene rearrangements were associated with overexpression of the Epo-R mRNA and protein argues for a role of this genetic alteration in the erythroid cell line phenotype. Recently, a highly significant link between a dominant Epo-R gene mutation and a familial erythrocytosis has been de~cribed.'~ This Epo-R defect gave rise to a protein truncated for 70 amino acids downstream of the mutation, leading to clinical erythrocytosis and to hypersensitivity to Epo of erythroid precursor cells in vitro." Until now, the onset of human erythroleukemia has not been shown to be related to alterations of chromosome 19, where the human Epo-R gene is located,36345 but several abnormalities involving this chromosome, among many others, were described in UT7 and TF-1 erythroleukemia cell lines. In UT7, two distinct rearrangements involve chromosome 19.
One is an unbalanced translocation of the long arm of chromosome 19 with another chromosome of unknown origin. This rearrangement occurred before the tetraploidization, as suggested by the presence of two identical derivative chromosomes. The other abnormality was a hsr (19) on which the Epo-R and LDL-R genes were found to be coamplified. In the hypothesis of a simple amplification process, this suggests that the amplicon was large, since the two genes involved are located at bands 19~13.2 or 19~13.1 and 19~13.3, respectively. It is usually difficult to detect, in a large amplicon, which genes are of imp~rtance~~; that Epo-R gene is highly transcribed suggests that this gene might be the target of the amplification and thus important in the leukemogenic process.
Finally, it remains to be determined whether Epo-R genetic defects could not be related to a selective pressure in in vitro cultures, and if they can be detected in de novo erythroleukemias. The screening of 23 Friend tumors in vivo failed to find any Epo-R abnormality with the probes mentioned earlier. A study of human erythroleukemias is currently in progress to determine whether Epo-R gene abnormalities are associated with these disorders.
